ATE323706T1 - Pyrazolopyridazinderivate - Google Patents

Pyrazolopyridazinderivate

Info

Publication number
ATE323706T1
ATE323706T1 AT02805104T AT02805104T ATE323706T1 AT E323706 T1 ATE323706 T1 AT E323706T1 AT 02805104 T AT02805104 T AT 02805104T AT 02805104 T AT02805104 T AT 02805104T AT E323706 T1 ATE323706 T1 AT E323706T1
Authority
AT
Austria
Prior art keywords
pyrazolopyridazine derivatives
pyrazolopyridazine
derivatives
Prior art date
Application number
AT02805104T
Other languages
English (en)
Inventor
Phillip Anthony Harris
David Kendall Jung
Michael Robert Peel
Michael John Reno
Tara Renae Rheault
Jennifer G Badiang
Kirk Lawrence Stevens
James Marvin Veal
Francis Xavier Tavares
Scott Howard Dickerson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE323706T1 publication Critical patent/ATE323706T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02805104T 2001-12-17 2002-12-11 Pyrazolopyridazinderivate ATE323706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34179801P 2001-12-17 2001-12-17

Publications (1)

Publication Number Publication Date
ATE323706T1 true ATE323706T1 (de) 2006-05-15

Family

ID=23339081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02805104T ATE323706T1 (de) 2001-12-17 2002-12-11 Pyrazolopyridazinderivate

Country Status (10)

Country Link
US (1) US7279473B2 (de)
EP (1) EP1463730B1 (de)
JP (1) JP2005524609A (de)
AR (1) AR037826A1 (de)
AT (1) ATE323706T1 (de)
AU (1) AU2002357164A1 (de)
DE (1) DE60210819T2 (de)
ES (1) ES2262899T3 (de)
TW (1) TW200301119A (de)
WO (1) WO2003051886A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1470124T3 (da) 2002-01-22 2006-04-18 Warner Lambert Co 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner
US7582630B2 (en) * 2002-10-15 2009-09-01 Smithkline Beecham Corporation Pyradazine compounds as GSK-3 inhibitors
MXPA06000484A (es) * 2003-07-11 2006-04-05 Warner Lambert Co Sal de isetionato de un inhibidor selectivo de la quinasa 4 dependiente de ciclina.
DE10344223A1 (de) * 2003-09-24 2005-04-21 Merck Patent Gmbh 1,3-Benzoxazolylderivate als Kinase-Inhibitoren
US7855205B2 (en) 2004-10-29 2010-12-21 Janssen Pharmaceutica Nv Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
TW200800213A (en) 2005-09-02 2008-01-01 Abbott Lab Novel imidazo based heterocycles
KR101152162B1 (ko) 2006-12-08 2012-07-10 에프. 호프만-라 로슈 아게 치환된 피리미딘 및 ｊｎｋ 조절제로서 그의 용도
KR20100098521A (ko) * 2007-12-07 2010-09-07 노파르티스 아게 피라졸 유도체 및 그의 사이클린 의존성 키나제 억제제로서의 용도
WO2009103032A1 (en) 2008-02-15 2009-08-20 Rigel Pharmaceuticals, Inc. Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
EP2924035A1 (de) * 2008-06-30 2015-09-30 Janssen Pharmaceutica NV Substituierte pyrimidinderivate
AR074870A1 (es) * 2008-12-24 2011-02-16 Palau Pharma Sa Derivados de pirazolo (1,5-a ) piridina
EP2668177B1 (de) * 2011-01-28 2014-10-22 Boehringer Ingelheim International GmbH Substituierte pyridinyl-pyrimidine und ihre verwendung als arzneimittel
US20150203812A1 (en) * 2014-01-20 2015-07-23 Francesco Tombola Inhibitors of Voltage Gated Ion Channels
GB201605126D0 (en) * 2016-03-24 2016-05-11 Univ Nottingham Inhibitors and their uses
CN106699608A (zh) * 2016-12-26 2017-05-24 常州大学 一种含有强吸电子基团的苯胍及其盐的制备方法
GB201715342D0 (en) * 2017-09-22 2017-11-08 Univ Nottingham Compounds
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
US11384083B2 (en) 2019-02-15 2022-07-12 Incyte Corporation Substituted spiro[cyclopropane-1,5′-pyrrolo[2,3-d]pyrimidin]-6′(7′h)-ones as CDK2 inhibitors
WO2020180959A1 (en) 2019-03-05 2020-09-10 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as cdk2 inhibitors
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
WO2020223469A1 (en) 2019-05-01 2020-11-05 Incyte Corporation N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
AR119765A1 (es) 2019-08-14 2022-01-12 Incyte Corp Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2
MX2022004390A (es) 2019-10-11 2022-08-08 Incyte Corp Aminas biciclicas como inhibidores de la cinasa dependiente de ciclina 2 (cdk2).
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622330B2 (en) 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
CA2291709A1 (en) * 1997-05-30 1998-12-03 Merck & Co., Inc. Novel angiogenesis inhibitors
DE69816651T2 (de) 1997-09-05 2004-04-01 Glaxo Group Ltd., Greenford 2,3-diaryl-pyrazolo[1,5-b]pyridazin derivate, deren herstellung und deren verwendung als cyclooxygenase 2 (cox-2) inhibitoren
AU3352899A (en) 1997-12-11 1999-07-12 American Home Products Corporation 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
CA2361139A1 (en) 1999-11-10 2001-05-17 Ortho-Mcneil Pharmaceutical, Inc. Substituted 2-aryl-3-(heteroaryl)-imidazo[1,2-a]pyrimidines, and related pharmaceutical compositions and methods
KR100876069B1 (ko) 2000-09-15 2008-12-26 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제 억제제로서 유용한 피라졸 화합물 및 이를 포함하는 약제학적 조성물
GB0103926D0 (en) 2001-02-17 2001-04-04 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
EP1463730B1 (de) 2006-04-19
DE60210819T2 (de) 2007-04-19
AR037826A1 (es) 2004-12-09
US20050090507A1 (en) 2005-04-28
DE60210819D1 (en) 2006-05-24
ES2262899T3 (es) 2006-12-01
US7279473B2 (en) 2007-10-09
TW200301119A (en) 2003-07-01
AU2002357164A8 (en) 2003-06-30
WO2003051886A1 (en) 2003-06-26
JP2005524609A (ja) 2005-08-18
WO2003051886A8 (en) 2004-08-19
EP1463730A1 (de) 2004-10-06
AU2002357164A1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
DE60220795D1 (de) Verschleissanordnung
ATE319451T1 (de) Tetrahydrochinolin-derivate
NO20033505L (no) Cannabinoidreseptorligander
NO20016086D0 (no) Avisingsopplösning
ATE323706T1 (de) Pyrazolopyridazinderivate
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
DE60116518D1 (de) Mehrzweckbohrwagen
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
FI20020283A (fi) Monitoimielin
DE60236345D1 (de) Rotordrehmomentprädiktor
ATE335486T1 (de) Hydrazono-malonitrile
DE1319930T1 (de) Coriolismassendurchflussmesser
DE50209410D1 (de) Kugelgelenk
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
ATE355059T1 (de) Isoxazolopyridinone
DE50201862D1 (de) Messwandler
NO20034649D0 (no) Tilstrammingsanordning
ATE319694T1 (de) Phenylalkyne
ATA18372001A (de) Gelenksbolzenbaueinheit
DE60202381D1 (de) Paroxetin-n-formyl-derivate
NO20021445L (no) Spröytestöpeform
DE10295006D2 (de) Bauwerksabdichtung
ATA13992002A (de) Schlackengranulierungsanlage
AT500276B8 (de) Radschwenksystem
ATE345337T1 (de) Delta1 -pyrroline

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties